M&T Bank Corp Guardant Health, Inc. Transaction History

M&T Bank Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $162,458 - $226,981	3,721 New	3,721 $202,000
Q2 2022 Aug 05, 2022	SELL	$28.82 - $77.35 $118,507 - $318,063	-4,112 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$48.25 - $100.49 $70,396 - $146,614	1,459 Added 54.99%	4,112 $272,000
Q4 2021 Feb 07, 2022	BUY	$88.71 - $120.43 $7,540 - $10,236	85 Added 3.31%	2,653 $266,000
Q3 2021 Oct 28, 2021	SELL	$98.77 - $132.17 $29,828 - $39,915	-302 Reduced 10.52%	2,568 $321,000
Q2 2021 Aug 13, 2021	BUY	$109.77 - $165.68 $25,356 - $38,272	231 Added 8.75%	2,870 $356,000
Q1 2021 May 06, 2021	SELL	$127.04 - $179.1 $442,480 - $623,805	-3,483 Reduced 56.89%	2,639 $402,000
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $26,089 - $35,477	261 Added 4.45%	6,122 $789,000
Q3 2020 Nov 06, 2020	BUY	$80.32 - $111.8 $110,520 - $153,836	1,376 Added 30.68%	5,861 $656,000
Q2 2020 Jul 29, 2020	BUY	$60.49 - $97.5 $62,244 - $100,327	1,029 Added 29.77%	4,485 $363,000
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $204,042 - $306,927	3,456 New	3,456 $241,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.